CMV is short for cytomegalovirus, a virus from the herpes – viruses class and it is the most common cause of infection during pregnancy in Israel and worldwide.
About 80% of the population in Israel has contracted the virus in childhood,[1] and for the most part, the infection is not accompanied by symptoms, or accompanied by mild symptoms of a cold, sore throat and fever.
The CMV virus does not pose a risk for the majority of the population, and in fact it may be safe to say that it is medically relevant to two major sections of the population:
Fetuses during the pregnancy of a woman who contracted the virus close to the time of the pregnancy or during the pregnancy.
When a pregnant woman contracts the CMV virus, the fetus is at risk of infection because the virus passes on from the maternal circulation to the placenta and from there (potentially) to the fetus.
If this is primary gestational infection, meaning that the pregnant woman has contracted the virus during the pregnancy for the first time in her life, the risk for fetal harm is higher than in non-primary infection.
You can read in more detail about the difference between primary infection and non-primary infection in the Q&A tab.
In the past, many doctors tended to recommend the termination of pregnancies in the event of maternal primary CMV infection during pregnancy, however, the current medical conception, based on many comprehensive studies conducted in Israel and around the world, is that in most cases there is room to continue the pregnancy, while conducting close follow-up and monitoring of the pregnancy by an infectious diseases specialist, CMV clinics or a gynecologist specializing in the subject.
Studies show that in most cases of infection with the virus the fetus will not be infected at all, and that even in the case of fetal infection – most fetuses infected with the CMV virus during pregnancy, will be born completely healthy.
Moreover, studies have found that usually, it is possible to see serious effects of the virus in targeted ultrasound scans and allow the parents to make the decision that is right for them. You can read in more detail about the targeted ultrasound scans in the tab follow-up on pregnant women with CMV.
CMV is short for cytomegalovirus, a virus from the herpes – viruses class and it is the most common cause of infection during pregnancy in Israel and worldwide.
About 80% of the population in Israel has contracted the virus in childhood,[1] and for the most part, the infection is not accompanied by symptoms, or accompanied by mild symptoms of a cold, sore throat and fever.
The CMV virus does not pose a risk for the majority of the population, and in fact it may be safe to say that it is medically relevant to two major sections of the population:
Fetuses during the pregnancy of a woman who contracted the virus close to the time of the pregnancy or during the pregnancy.
When a pregnant woman contracts the CMV virus, the fetus is at risk of infection because the virus passes on from the maternal circulation to the placenta and from there (potentially) to the fetus.
If this is primary gestational infection, meaning that the pregnant woman has contracted the virus during the pregnancy for the first time in her life, the risk for fetal harm is higher than in non-primary infection.
You can read in more detail about the difference between primary infection and non-primary infection in the Q&A tab.
In the past, many doctors tended to recommend the termination of pregnancies in the event of maternal primary CMV infection during pregnancy, however, the current medical conception, based on many comprehensive studies conducted in Israel and around the world, is that in most cases there is room to continue the pregnancy, while conducting close follow-up and monitoring of the pregnancy by an infectious diseases specialist, CMV clinics or a gynecologist specializing in the subject.
Studies show that in most cases of infection with the virus the fetus will not be infected at all, and that even in the case of fetal infection – most fetuses infected with the CMV virus during pregnancy, will be born completely healthy.
Moreover, studies have found that usually, it is possible to see serious effects of the virus in targeted ultrasound scans and allow the parents to make the decision that is right for them. You can read in more detail about the targeted ultrasound scans in the tab follow-up on pregnant women with CMV.
The information on the site is updated as of its upload date. It only intends to provide information and is does not constitute and/or does not claim to a substitute for medical advice, medical opinion, exhaustive research on the subject or consultation with a healthcare specialist. Use of the website is the sole responsibility of its users and it does not replace the responsibility of the users to receive individual consultation by a qualified healthcare party, on a case by case basis. The website’s administration requests to stress that anyone searching for information on CMV must seek appropriate healthcare consultation.
Welcome to www.cmv.co.il – the website for the Israeli Association for CMV Pregnancy.
Users of the site must read these terms carefully before using the site, as using the site indicates the user’s consent to the terms.
The information on the site is updated as of its upload date. It only intends to provide information and is does not constitute and/or does not claim to a substitute for medical advice, medical opinion, exhaustive research on the subject or consultation with a healthcare specialist.
Use of the website is the sole responsibility of its users and it does not replace the responsibility of the users to receive individual consultation by a qualified healthcare party, on an individual case basis.
The website’s administration would like to stress that anyone seeking information on CMV must refer to appropriate healthcare consultation.
Users will have no claim, complaint or demand against the Association concerning the information presented on or through this site, its accuracy, reliability, completeness, relevancy, and the frequency of its publication.
Use of the information on the site and reliance on it will be the sole and complete responsibility of the users.
The Association reserves the right to update, modify, add or remove anything, without prior or late notice, at its sole discretion.
All copyright and intellectual property on the site belong to the Association, unless explicitly stated that the copyright of the protected information, or any part thereof, belongs to another party.
No part of the protected information may be copied, reproduced, distributed, marketed, publicly distributed, translated or disclosed to any third party without receiving the explicit written consent of the Association in advance.
I ratify my consent